𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Alteration of adipokines during peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor

✍ Scribed by Yoshinori Tanaka; Toshiaki Yujiri; Mayumi Tanaka; Noriyuki Mitani; Atsuko Tanimura; Yukio Tanizawa


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
100 KB
Volume
24
Category
Article
ISSN
0733-2459

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Adipokines, soluble mediators produced by adipocytes, have been shown to play a role in various physiological and pathological conditions. We investigated the involvement of adipokines in granulocyte colony‐stimulating factor (G‐CSF)‐induced mobilization of hematopoietic stem cells in 21 healthy donors. We found that serum visfatin and resistin levels, but not leptin and adiponectin levels, were significantly elevated by G‐CSF treatment. G‐CSF treatment activated signaling proteins like extracellular signal‐regulated kinase and stimulated secretion of visfatin from 3T3‐L1 adipocytes. These findings suggest that some adipokines may play a role in G‐CSF‐induced mobilization of stem cells from the bone marrow into systemic circulation. J. Clin. Apheresis 2009. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Predictive parameters for granulocyte co
✍ Akira Okano; Eishi Ashihara; Chihiro Shimazaki; Hitoji Uchiyama; Tohru Inaba; Ky 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract To improve the selection of donors for allogeneic stem cell transplantation, it is important to identify reliable parameters that predict CD34+‐cell yields after granulocyte‐colony stimulating factor (G‐CSF)‐induced peripheral blood stem cell (PBSC) mobilization. We retrospectively inve

Collection efficiency on the fenwal CS30
✍ L. Bik To; German R. Stemmelin; David N. Haylock; Joanne L. Bayly; Dawn Thorp; C 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB

## Abstract The collection efficiency (CE) of the Fenwal CS3000 in collecting peripheral blood stem cells during post‐chemotherapy recovery phase ranges from 58% to 73%. Recently filgrastim (recombinant methionyl human granulocyte colony‐stimulating factor [G‐CSF]) has also been shown to be effecti